VALN (Valneva SE) Cyclically Adjusted Revenue per Share: $4.24 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VALN Valneva SE VALN
49 GF Score
Price $6.96
GF Value $5.28
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Cyclically Adjusted Revenue per Share?

Valneva SE VALN +2.05% 49 Cyclically Adjusted Revenue per Share is $4.24 as of Jun. 2026. GuruFocus rates VALN with a GF Score™ of 49/100 and a GF Value™ of $5.28 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Valneva SE's adjusted revenue per share for the three months ended in Jun. 2026 was $0.439. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $4.24 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Valneva SE's average Cyclically Adjusted Revenue Growth Rate was -2.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Valneva SE was 17.60% per year. The lowest was 2.50% per year. And the median was 13.10% per year.

As of today (2026-08-24), Valneva SE's current stock price is $6.96. Valneva SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $4.24. Valneva SE's Cyclically Adjusted PS Ratio of today is 1.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Valneva SE was 23.42. The lowest was 1.00. And the median was 3.11.


Valneva SE  (NAS:VALN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Valneva SE's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.96/4.24
=1.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Valneva SE was 23.42. The lowest was 1.00. And the median was 3.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Valneva SE Cyclically Adjusted Revenue per Share Related Terms


Valneva SE Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Valneva SE's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Cyclically Adjusted Revenue per Share Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.15 3.49 3.93 3.74 4.36

Valneva SE Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.51 4.56 4.36 4.08 4.24

VALN vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Valneva SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Valneva SE's Cyclically Adjusted PS Ratio falls into.


VALN
49GF Score
Valneva SE VALN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Valneva SE's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.439/123.5100*123.5100
=0.439

Current CPI (Jun. 2026) = 123.5100.

Valneva SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.530 100.340 0.652
201612 0.744 100.650 0.913
201703 0.734 101.170 0.896
201706 0.633 101.320 0.772
201709 0.623 101.330 0.759
201712 0.905 101.850 1.097
201803 1.085 102.750 1.304
201806 0.760 103.370 0.908
201809 0.591 103.560 0.705
201812 0.958 103.470 1.144
201903 0.812 103.890 0.965
201906 0.705 104.580 0.833
201909 0.711 104.500 0.840
201912 0.806 104.980 0.948
202003 0.846 104.590 0.999
202006 0.314 104.790 0.370
202009 0.293 104.550 0.346
202012 1.361 104.960 1.602
202103 0.599 105.750 0.700
202106 0.600 106.340 0.697
202109 0.505 106.810 0.584
202112 6.514 107.850 7.460
202203 0.444 110.490 0.496
202206 1.390 112.550 1.525
202209 2.927 112.740 3.207
202212 1.700 114.160 1.839
202303 0.515 116.790 0.545
202306 0.619 117.650 0.650
202309 0.601 118.260 0.628
202312 0.658 118.390 0.686
202403 0.496 119.470 0.513
202406 0.588 120.200 0.604
202409 0.663 119.560 0.685
202412 0.650 119.950 0.669
202503 0.692 120.380 0.710
202506 0.670 121.360 0.682
202509 0.381 120.950 0.389
202512 0.652 120.900 0.666
202603 0.401 122.420 0.405
202606 0.439 123.510 0.439

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $4.24 mean?
Valneva SE (VALN) has a Cyclically Adjusted Revenue per Share of $4.24 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Valneva SE and its competitors.
Is Valneva SE's Cyclically Adjusted Revenue per Share too high?
Valneva SE's current Cyclically Adjusted Revenue per Share is $4.24. Overall, Valneva SE has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Valneva SE's Cyclically Adjusted Revenue per Share of $4.24 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Valneva SE and its competitors. Valneva SE's current Cyclically Adjusted Revenue per Share is $4.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (VALN) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.28, compared to a current price of $6.96 — trading 31.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $4.24. Valneva SE's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Valneva SE (VALN), the current Cyclically Adjusted Revenue per Share is $4.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valneva SE (VALN) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be overvalued. The current stock price of $6.96 is trading 31.8% above its estimated GF Value™ of $5.28. GuruFocus considers Valneva SE to be Significantly Overvalued.

Key valuation signals for VALN:

  • Cyclically Adjusted Revenue per Share: $4.24
  • GF Value™: $5.28 vs. price of $6.96 (31.8% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the VALN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
49GF Score

Get the complete analysis for VALN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.96
Price
$5.28
GF Value